Hydrogen in Patients With Corticosteroid-Refractory/Dependent Chronic Graft-Versus-Host-Disease: A Single-Arm, Multicenter, Open-Label, Phase 2 Trial

Hydrogen Water Shows Promise for Chronic Graft-Versus-Host-Disease Patients

A recent study found that drinking hydrogen water may help patients with chronic graft-versus-host-disease, a condition that can occur after a bone marrow transplant. The study showed promising results, with most patients experiencing significant improvement in their symptoms. Hydrogen water may offer a new hope for patients with limited treatment options.